Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNJ | NVO | ABBV | ||
| Company | Johnson & Johnson | Novo Nordisk A/S ADR | Abbvie Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 159.70 | 110.19 | 203.79 | ||
| High | 160.28 | 110.66 | 204.24 | ||
| Low | 158.07 | 109.44 | 200.22 | ||
| Last | 158.24 | 109.72 | 200.47 | ||
| Change | -1.89 | -2.22 | -3.08 | ||
| % Change | -1.18% | -1.98% | -1.51% | ||
| Volume | 4,644,000 | 6,215,000 | 3,531,800 | ||
| 20-Day Average Volume | 5,972,350 | 4,712,320 | 5,185,680 | ||
| Previous Close | 160.13 | 111.94 | 203.55 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 161.96 | 115.59 | 193.04 | ||
| 20-Day Raw Stochastic | 1.96% | 18.62% | 68.04% | ||
| 20-Day Relative Strength | 41.36% | 31.24% | 59.70% | ||
| Weighted Alpha | +5.90 | -3.17 | +41.62 | ||
| Today's Opinion | 24% Buy | 88% Sell | 88% Buy | ||
| Previous Opinion | 40% Buy | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 72% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.08% since 10/28/24 | -2.35% since 10/28/24 | +5.69% since 10/28/24 | ||
| Low | 158.07 on 11/04/24 | 107.24 on 10/30/24 | 188.51 on 10/29/24 | ||
| High | 162.17 on 10/29/24 | 113.76 on 10/30/24 | 207.32 on 10/31/24 | ||
| 1-Month | |||||
| %Chg | -1.28% since 10/04/24 | -4.69% since 10/04/24 | +3.18% since 10/04/24 | ||
| Low | 158.07 on 11/04/24 | 107.24 on 10/30/24 | 185.89 on 10/21/24 | ||
| High | 166.75 on 10/15/24 | 120.56 on 10/11/24 | 207.32 on 10/31/24 | ||
| 3-Month | |||||
| %Chg | -3.59% since 08/02/24 | -13.94% since 08/02/24 | +5.91% since 08/02/24 | ||
| Low | 156.44 on 08/13/24 | 107.24 on 10/30/24 | 183.04 on 08/05/24 | ||
| High | 168.85 on 09/04/24 | 139.74 on 08/30/24 | 207.32 on 10/31/24 | ||
| 6-Month | |||||
| %Chg | +6.01% since 05/03/24 | -10.83% since 05/03/24 | +22.39% since 05/03/24 | ||
| Low | 143.71 on 05/29/24 | 107.24 on 10/30/24 | 153.58 on 05/30/24 | ||
| High | 168.85 on 09/04/24 | 148.15 on 06/25/24 | 207.32 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 385,532,672 | 502,334,368 | 359,539,328 | ||
| Shares Outstanding, K | 2,407,623 | 4,487,532 | 1,766,344 | ||
| Annual Sales | 85,159,000,000 | 33,724,300,000 | 54,318,000,000 | ||
| Annual Net Income | 35,153,000,000 | 12,150,770,000 | 4,863,000,000 | ||
| Last Quarter Sales | 22,471,000,000 | 9,821,060,000 | 14,462,000,000 | ||
| Last Quarter Net Income | 2,694,000,000 | 2,893,220,000 | 1,370,000,000 | ||
| 60-Month Beta | 0.52 | 0.43 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.42 on 10/15/24 | 0.65 on 08/07/24 | 3.00 on 10/30/24 | ||
| Latest Earnings Date | 10/15/24 | 11/06/24 | 10/30/24 | ||
| Most Recent Dividend | 1.240 on 08/27/24 | 0.362 on 08/16/24 | 1.550 on 10/15/24 | ||
| Next Ex-Dividends Date | 11/26/24 | 08/16/24 | 01/15/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 15.61 | 38.34 | 18.96 | ||